claim: fda approves no access to wilmington company's experimental covid-19 therapy
evidence_1: the protocol specifically makes the treatment available to pregnant women.", "dr. jonathan javitt, chairman and ceo of neurorx, said the company's application covers the same type of coronavirus patients whom the fda has already allowed to receive treatment under an expanded access protocol authorized by the federal agency in july.")